share_log
Moomoo 24/7 ·  Apr 15 07:31
FDA Grants Soligenix Orphan Drug Designation To Active Ingredient In MarVaxor For Prevention And Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment